Medical Device Manufacturers Eye Costa Rica as Tariff Uncertainty Shakes up Production Strategies. Amid rising tariff uncertainty, Medtech manufacturers are increasingly considering Costa Rica as a strategic alternative to China for production. With its skilled workforce, tax incentives, and established medical device ecosystem, Costa Rica is becoming a key destination for global life sciences companies seeking stability and cost advantages. That opens the door for bad actors throughout the supply chain, as well as counterfeiting. Ganzarski stressed that manufacturers need to establish transparency and traceability, which can lead to trust.